Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte-derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibit...
Main Authors: | Poole, K, van Bezooijen, R, Loveridge, N, Hamersma, H, Papapoulos, SE, Löwik, C, Reeve, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
Sclerostin expression by osteocytes is a delayed event; Implications for the control of bone formation
by: Poole, K, et al.
Published: (2005) -
Selerostin is a delayed secreted product of osteocytes that regulates BMU width and cortical canal infilling
by: Poole, K, et al.
Published: (2005) -
Osteocyte sclerostin expression: Regulator of BMU balance in osteoarthritis and osteoporosis?
by: Loveridge, N, et al.
Published: (2007) -
Osteocytic sclerostin expression is locally reduced at the site of femoral neck fracture
by: Power, J, et al.
Published: (2011) -
Is sclerostin expression a common modulator of the effects of osteoporosis and osteoarthritis on bone formation?
by: Loveridge, N, et al.
Published: (2007)